Paying users zone. Data is covered by hidden.

  • Get 1-month access to Gilead Sciences Inc. for $17.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Gilead Sciences Inc. (GILD)


Analysis of Profitability Ratios

Difficulty: Beginner


Profitability Ratios (Summary)

Gilead Sciences Inc., profitability ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Return on Sales
Gross profit margin hidden hidden hidden hidden hidden
Operating profit margin hidden hidden hidden hidden hidden
Net profit margin hidden hidden hidden hidden hidden
Return on Investment
Return on equity (ROE) hidden hidden hidden hidden hidden
Return on assets (ROA) hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Gilead Sciences Inc.’s gross profit margin ratio deteriorated from 2016 to 2017 and from 2017 to 2018.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Gilead Sciences Inc.’s operating profit margin ratio deteriorated from 2016 to 2017 and from 2017 to 2018.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Gilead Sciences Inc.’s net profit margin ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Gilead Sciences Inc.’s ROE deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.
ROA A profitability ratio calculated as net income divided by total assets. Gilead Sciences Inc.’s ROA deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Gross Profit Margin

Gilead Sciences Inc., gross profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Gross profit on product sales hidden hidden hidden hidden hidden
Product sales hidden hidden hidden hidden hidden
Profitability Ratio
Gross profit margin1 hidden hidden hidden hidden hidden
Benchmarks
Gross Profit Margin, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
Gross profit margin = 100 × Gross profit on product sales ÷ Product sales
= 100 × hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Gilead Sciences Inc.’s gross profit margin ratio deteriorated from 2016 to 2017 and from 2017 to 2018.

Operating Profit Margin

Gilead Sciences Inc., operating profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Income from operations hidden hidden hidden hidden hidden
Product sales hidden hidden hidden hidden hidden
Profitability Ratio
Operating profit margin1 hidden hidden hidden hidden hidden
Benchmarks
Operating Profit Margin, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Operating Profit Margin, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Operating Profit Margin, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
Operating profit margin = 100 × Income from operations ÷ Product sales
= 100 × hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Gilead Sciences Inc.’s operating profit margin ratio deteriorated from 2016 to 2017 and from 2017 to 2018.

Net Profit Margin

Gilead Sciences Inc., net profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Net income attributable to Gilead hidden hidden hidden hidden hidden
Product sales hidden hidden hidden hidden hidden
Profitability Ratio
Net profit margin1 hidden hidden hidden hidden hidden
Benchmarks
Net Profit Margin, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Net Profit Margin, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Net Profit Margin, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
Net profit margin = 100 × Net income attributable to Gilead ÷ Product sales
= 100 × hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Gilead Sciences Inc.’s net profit margin ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Return on Equity (ROE)

Gilead Sciences Inc., ROE calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Net income attributable to Gilead hidden hidden hidden hidden hidden
Total Gilead stockholders’ equity hidden hidden hidden hidden hidden
Profitability Ratio
ROE1 hidden hidden hidden hidden hidden
Benchmarks
ROE, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
ROE, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
ROE, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
ROE = 100 × Net income attributable to Gilead ÷ Total Gilead stockholders’ equity
= 100 × hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Gilead Sciences Inc.’s ROE deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Return on Assets (ROA)

Gilead Sciences Inc., ROA calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Net income attributable to Gilead hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Profitability Ratio
ROA1 hidden hidden hidden hidden hidden
Benchmarks
ROA, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
ROA, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
ROA, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25).

1 2018 Calculation
ROA = 100 × Net income attributable to Gilead ÷ Total assets
= 100 × hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Gilead Sciences Inc.’s ROA deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.